Table 5

Sensitivity analysis for missing postoperative data restricted to the seven British Society for Gynaecological Endoscopy (BSGE) endometriosis centres with the most complete follow-up

Short term (6 months)*Long term (2 years)*Range
Symptoms
 Premenstrual pain107(0–10)
 Menstrual pain109(0–10)
 Non-cyclical pelvic pain105(0, 10)
 Deep dyspareunia105(0, 10)
 Cyclical dyschezia105(0–10)
 Non-cyclical dyschezia74(0–10)
 Low back pain105(0–10)
 Bladder pain41(0–10)
 Voiding difficulty1NS(0–10)
 Frequent bowel movements†2NS(0–4)
 Urgent bowel movements†3NS(0–4)
 Incomplete bowel movements†2NS(0– 4)
 Constipation†2NS(0–4)
 Blood in the stool†21(0–4)
Quality of life†
 EQ visual analogue score055(0–100)
 EQ5D usual activities11(0–2)
 EQ5D pain and discomfort22(0–2)
 EQ5D anxiety and depression21(0–2)
 EQ5D mobility01(0–2)
 EQ5D self-care1NS(0–2)
 EQ5D index−0.5940.65(−0.594 to 1)
  • *The worst possible score that could be reported for all the missing postoperative data in order for the short-term (6 months) or long-term statistics in tables 3 and 4 to still be significant. (The test statistics that were not significant (NS) to start with have not been included.)

  • †A high EQVAS or EQ5D index score is associated with an improvement in QoL, whereas with all other QoL and symptom scores, a low value is associated with improvement.

  • EQVAS, EuroQol Visual Analogue Scale; EQ5D, EuroQol 5D; QoL, quality of life.